Hepatitis_C_antibody_in_patients_with_chronic_liver_disease_and_hepatocellular_carcinoma._Hepatitis_C_virus_(HCV)_is_the_major_etiologic_agent_of_parenterally_transmitted_non-A,_non-B_hepatitis._To_determine_whether_there_is_a_relationship_between_this_virus_agent_and_hepatocellular_carcinoma_(HCC),_the_sera_of_patients_with_HCC_and_chronic_hepatitis_were_assessed_using_a_sensitive_immunoassay_for_HCV_antibody._Anti-HCV_was_detected_in_65%_of_132_patients_with_HCC,_without_any_relationship_with_the_presence_of_the_hepatitis_B_surface_antigen_(HBsAg)._The_prevalence_(74%)_of_anti-HCV_was_high,_as_expected_in_patients_with_putative_non-A,_non-B_cirrhosis_also._The_prevalence_of_anti-HCV_was_less_in_patients_with_HBsAg-positive_cirrhosis_(28%)_and_in_patients_with_disease_not_related_to_viral_hepatitis_and_healthy_controls_(8%)._These_data_suggest,_but_do_not_prove,_that_HCV_is_an_important_factor_associated_with_HCC.